A leukotriene B(4) receptor-2 is associated with paclitaxel resistance in MCF-7/DOX breast cancer cells

BACKGROUND: Breast cancer is the most common malignancy in women. Although chemotherapeutic agents, such as paclitaxel, are effective treatments for the majority of breast cancer patients, recurrence is frequent and often leads to death. Thus, there is an urgent need to identify novel therapeutic ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, H, Park, G-S, Lee, J E, Kim, J-H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721398/
https://www.ncbi.nlm.nih.gov/pubmed/23799854
http://dx.doi.org/10.1038/bjc.2013.333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721398/
https://www.ncbi.nlm.nih.gov/pubmed/23799854
http://dx.doi.org/10.1038/bjc.2013.333

Ejemplares similares